New hope for severe asthma patients who Don't respond to standard treatments
NCT ID NCT05564078
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study looked at 30 adults with severe asthma whose symptoms didn't improve with usual treatments. Researchers tested whether dupilumab, a drug that blocks certain inflammatory signals, could reduce signs of the immune system attacking the airways. The goal was to see if this approach could help control asthma better by lowering autoimmune markers in the lungs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AIRWAY AUTO IMMUNITY IN ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Research Institute of St. Joe's Hamilton
Hamilton, Ontario, L8N4A6, Canada
Conditions
Explore the condition pages connected to this study.